Skip to main content

Table 1 Reported treatment coverage during ivermectin and albendazole MDA intervention in Rufiji District, southeastern Tanzania

From: Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration

MDA No.

Treatment year

Target population

Treated population (% coverage)

1

2002

138,370

75,135 (54.3)

2

2003

141,628

123,216 (87.0)

3

2004

144,962

136,267 (94.0)

 

2005a

–

–

4

2006

151,868

85,046 (56.0)

5

2007

155,443

116,583 (75.0)

6

2008

159,103

115,350 (72.5)

7

2009

162,848

130,279 (80.0)

8

2010

166,682

113,677 (68.2)

9

2011

170,606

150,133 (88.0)

10

2012

236,614

146,060 (61.7)

11

2013

243,835

149,163 (61.2)

12

2014

217,274

168,930 (77.7)

  1. aMDA was not implemented in 2005